EBV EA (Early Antigen) IgM ELISA Kit


Human EBV EA IgM ELISA kit is a procedure for analysing in-vitro quantitative levels of human IgM antibodies to the Epstein–Barr virus early antigen (EBV EA IgM) using samples of plasma or serum. This assay has a minimum analytical sensitivity limit of 1.1 U/ml.


Epstein–Barr virus (EBV) can also be referred to as human herpesvirus 4 (HHV-4) and it belongs to the family of viruses known as herpes. EBV is responsible for causing infectious mononucleosis, an illness which is associated with sore throat, fever, swollen lymph nodes and sometimes enlarged spleen. This virus is able to spread through many commonly bodily fluids, especially saliva. It is also able to spread through blood and semen, organ transplantations and blood transfusions. A large number of these viral infections have been linked to autoimmune diseases for example Sjögren’s syndrome, multiple sclerosis, dermatomyositis, systemic lupus erythematosus and rheumatoid arthritis. EBV Early antigen (EBV EA) can be associated to a number of different acute phase illness, however, after 3-6 months the levels become undetectable.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • EBV Early Antigen coated microtiter strips.
  • Calibrator B (Cut-Off Standard).
  • Calibrator D (Positive Control).
  • Calibrator A (Negative Control).
  • Calibrator C (Weak Positive Control).
  • Sample Diluent.
  • Enzyme Conjugate.
  • TMB Substrate.
  • Washing Buffer (10x).
  • Stop Solution.


The minimum detection sensitivity level of IgM antibodies directed to Epstein–Barr virus early antigen (EBV EA-IgM) using current human EBV EA IgM ELISA kit was 1.1 U/ml. The dynamic range for this assay is 1.0 – 200.0 U/ml.


– Intra-Assay-Precision: 6.2 %.
– Inter-Assay-Precision: 10.5 %.
– Inter-Lot-Precision: 2.4 – 11.1 %.
– Analytical Sensitivity: 1.10 U/mL.
– Recovery: 71 – 111 %.
– Linearity: 73 – 112 %.
– Cross-Reactivity: No cross-reactivity to Herpes, Measles, Mumps and Varicella.
– Interferences: No interferences to bilirubin up to 0.3 mg/mL, hemoglobin up to 8.0 mg/mL and triglycerides up to 5.0 mg/mL.
– Clinical Specificity: 100 %
– Clinical Sensitivity 85 %


  1. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo. (2004) 18 (2): 101-6. Lerner A.M., et al.
  2. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scand J Rheumatol. (2015) 44 (2): 143-9. Rasmussen N.S., et al.
  3. Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J Virol Methods. (1988) 21 (1-4): 133-46. Middeldorp J.M., Herbrink P.
  4. EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement? Rheumatol Int. (2013) 33 (5): 1149-57. Pasoto S.G., et al.
  5. Antibodies to Epstein-Barr virus-induced early antigens in blood donors. Acta Virol. (1989) 33 (4): 344-8. Wohlrabe P., et al.


  • Full Name: EBV EA (Early Antigen) IgM ELISA Kit
  • Reactivity: Human
  • Sample Type: Plasma, Serum
  • Sensitivity: 1.1 U/ml



Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford